← 返回

单核细胞-巨噬细胞动态是严重抗黑色素瘤分化相关基因 5 阳性皮肌炎相关间质性肺病中肺部与外周免疫反应差异的关键

英文原题:Monocyte-macrophage dynamics as key in disparate lung and peripheral immune responses in severe anti-melanoma differentiation-associated gene 5-positive dermatomyositis-related interstitial lung disease.

查看英文原题

Monocyte-macrophage dynamics as key in disparate lung and peripheral immune responses in severe anti-melanoma differentiation-associated gene 5-positive dermatomyositis-related interstitial lung disease.

PubMed 2025/02/01(内容时间) Clin Transl Med Q1 · IF 7.9(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

我们的研究强调了单核细胞-巨噬细胞动态在抗 MDA5+相关 RP-ILD 免疫发病机制中的关键作用,为区室特异性免疫失调提供了重要见解。这些发现提示了靶向单核细胞募集和巨噬细胞活化以减缓疾病进展的潜在治疗策略。外周免疫抑制和肺部免疫过度活化是抗 MDA5+DM 伴 RP-ILD 独特免疫景观的特征。循环单核细胞从外周的免疫抑制表型转变为肺部促炎和促纤维化的 Mo-AMs。Mo-AMs 产生的趋化因子驱动单核细胞和其他免疫细胞向肺部募集,放大肺部炎症。

研究思路结论见上方概要

抗黑色素瘤分化相关基因5阳性皮肌炎(anti-MDA5+ DM)是一种罕见的炎症性自身免疫性疾病,常并发危及生命的快速进展性间质性肺病(RP-ILD)。然而,驱动免疫功能障碍和肺损伤的潜在机制仍知之甚少。本研究旨在深入了解重症anti-MDA5+ DM外周和肺部免疫微环境的紊乱,并探索潜在的治疗靶点。

我们采用单细胞RNA测序技术,对5名患者支气管肺泡灌洗液及配对的外周血单个核细胞中的细胞成分进行了分析。进一步运用Luminex检测和流式细胞术对结果进行验证。

我们的分析揭示了外周与肺之间截然不同的免疫景观,外周免疫抑制与肺免疫过度激活并存。这种失调的核心是单核细胞-巨噬细胞谱系。循环单核细胞表现出免疫抑制表型,其特征为细胞因子产生减少、MHC II表达降低以及类似髓源性抑制细胞的特征。这些单核细胞被募集到肺,在那里分化为具有强烈促炎和促纤维化活性的单核细胞来源肺泡巨噬细胞(Mo-AMs)。Mo-AMs驱动细胞因子风暴并产生趋化因子,从而放大炎症细胞募集和肺组织重塑。此外,外周T细胞和NK细胞表现出细胞死亡增加和向肺的活跃迁移,这可能是淋巴细胞减少的原因。

展开英文摘要原文

Anti-melanoma differentiation-associated gene 5-positive dermatomyositis (anti-MDA5+ DM) is a rare inflammatory autoimmune disorder often complicated by life-threatening rapidly progressive interstitial lung disease (RP-ILD). The underlying mechanisms driving immune dysfunction and lung injury, however, remain poorly understood. The study aims to gain insights into the disrupted immune landscape in peripheral and pulmonary compartments of severe anti-MDA5+ DM and explore potential therapeutic targets.

We employed single-cell RNA sequencing to examine cellular constituents within five patients' bronchoalveolar lavage fluid and paired peripheral blood mononuclear cells. Luminex assay and flow cytometry were further applied to validate the results.

Our analysis revealed starkly contrasting immune landscapes between the periphery and lungs, with peripheral immune suppression juxtaposed against pulmonary immune hyperactivation. Central to this dysregulation was the monocyte-macrophage lineage. Circulating monocytes exhibited an immunosuppressive phenotype, characterised by diminished cytokine production, reduced MHC II expression, and features resembling myeloid-derived suppressor cells. These monocytes were recruited to the lungs, where they differentiated into monocyte-derived alveolar macrophages (Mo-AMs) with robust proinflammatory and profibrotic activities. Mo-AMs drove cytokine storms and produced chemokines that amplified inflammatory cell recruitment and lung tissue remodelling. Additionally, peripheral T and NK cells exhibited increased cell death and active migration into the lungs, which may be the cause of lymphopenia.

Our study underscores the pivotal role of monocyte-macrophage dynamics in the immunopathogenesis of anti-MDA5+-associated RP-ILD, offering critical insights into compartment-specific immune dysregulation. These findings suggest potential therapeutic strategies targeting monocyte recruitment and macrophage activation to mitigate disease progression. KEY POINTS: Peripheral immune suppression and pulmonary immune hyperactivation characterise the distinct immune landscapes in anti-MDA5+DM with RP-ILD. Circulating monocytes transition from an immunosuppressive phenotype in the periphery to proinflammatory and profibrotic Mo-AMs in the lungs. Chemokines produced by Mo-AMs drive monocyte and other immune cell recruitment to the lungs, amplifying pulmonary inflammation.

论文信息

作者
Shi J、Pei X、Peng J、Wu C、Lv Y、Wang X、Zhou Y、Yuan X
第一作者单位
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Complex Severe and Rare Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.China
通讯作者单位
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, State Key Laboratory of Common Mechanism Research for Major Diseases, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, China.China
文献类型
非美国政府资助研究
期刊
Clinical and translational medicine2025 Feb
原文标识
PubMed 39902678 · DOI 10.1002/ctm2.70226